ProCE Banner Activity

Infection Incidence With Upadacitinib in Patients With Rheumatoid Arthritis

Slideset Download
Conference Coverage
In this descriptive analysis, upadacitinib 30 mg was associated with a higher rate of serious and opportunistic infections, including herpes zoster, compared with the 15 mg dose.

Released: July 07, 2020

Expiration: July 06, 2021

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Gilead Sciences, Inc.